Recall record at a glance
| Official record | F-2129-2012 |
|---|---|
| Category | Food Recalls |
| Classification | Class II |
| FDA record status | Terminated |
| Recalling firm | Clif Bar And Company |
| Report date | Sep 12, 2012 |
| Recall initiation date | Aug 13, 2012 |
| Quantity | 384 Boxes |
| Location | Emeryville, CA, United States |
Official product description
Blueberry Crisp CLIF Bars, 12 pack boxes, UPC: 7-22252-30260-1
Why the product was recalled
A small amount of Blueberry Crisp CLIF bars were inadvertently placed in Chocolate Chip CLIF bar wrappers and placed inside correctly labeled Blueberry Crisp CLIF bar 12-pack boxes. Retailers sell to consumers in 12-pack boxes, and sometimes as individual bars.
Distribution information
The distributors in MA and WI.
How to read the classification
FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Press Release.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.